Artikler med mandater om offentlig tilgang - Michele TavecchioLes mer
Tilgjengelige et eller annet sted: 11
Chemosensitization of cancer cells by KU-0060648, a dual inhibitor of DNA-PK and PI-3K
JM Munck, MA Batey, Y Zhao, H Jenkins, CJ Richardson, C Cano, ...
Molecular cancer therapeutics 11 (8), 1789-1798, 2012
Mandater: Cancer Research UK
Adaptive mitochondrial reprogramming and resistance to PI3K therapy
JC Ghosh, MD Siegelin, V Vaira, A Faversani, M Tavecchio, YC Chae, ...
Journal of the National Cancer Institute 107 (3), dju502, 2015
Mandater: US National Institutes of Health
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α
S Basu, K Gnanapradeepan, T Barnoud, CP Kung, M Tavecchio, J Scott, ...
Genes & development 32 (3-4), 230-243, 2018
Mandater: US National Institutes of Health
Further characterisation of the cellular activity of the DNA-PK inhibitor, NU7441, reveals potential cross-talk with homologous recombination
M Tavecchio, JM Munck, C Cano, DR Newell, NJ Curtin
Cancer chemotherapy and pharmacology 69, 155-164, 2012
Mandater: Cancer Research UK
Deletion of the mitochondrial chaperone TRAP-1 uncovers global reprogramming of metabolic networks
S Lisanti, M Tavecchio, YC Chae, Q Liu, AK Brice, ML Thakur, ...
Cell Reports 8 (3), 671-677, 2014
Mandater: US National Institutes of Health
Targeted inhibition of mitochondrial Hsp90 suppresses localised and metastatic prostate cancer growth in a genetic mouse model of disease
BH Kang, M Tavecchio, HL Goel, CC Hsieh, DS Garlick, CM Raskett, ...
British journal of cancer 104 (4), 629-634, 2011
Mandater: US National Institutes of Health
Cyclophilin D Extramitochondrial Signaling Controls Cell Cycle Progression and Chemokine-directed Cell Motility*[S]
M Tavecchio, S Lisanti, A Lam, JC Ghosh, NM Martin, M O'Connell, ...
Journal of Biological Chemistry 288 (8), 5553-5561, 2013
Mandater: US National Institutes of Health
Deletion of cyclophilin D impairs β-oxidation and promotes glucose metabolism
M Tavecchio, S Lisanti, MJ Bennett, LR Languino, DC Altieri
Scientific reports 5 (1), 15981, 2015
Mandater: US National Institutes of Health
Transgenic expression of the mitochondrial chaperone TNFR-associated protein 1 (TRAP1) accelerates prostate cancer development
S Lisanti, DS Garlick, KG Bryant, M Tavecchio, GB Mills, Y Lu, ...
Journal of Biological Chemistry 291 (48), 25247-25254, 2016
Mandater: US National Institutes of Health
Chk2 phosphorylation of survivin-ΔEx3 contributes to a DNA damage–sensing checkpoint in cancer
A Lopergolo, M Tavecchio, S Lisanti, JC Ghosh, T Dohi, A Faversani, ...
Cancer research 72 (13), 3251-3259, 2012
Mandater: US National Institutes of Health
Synergistic Effects of Sanglifehrin-Based Cyclophilin Inhibitor NV651 with Cisplatin in Hepatocellular Carcinoma
S Simón Serrano, M Tavecchio, J Mallik, A Grönberg, E Elmér, C Kifagi, ...
Cancers 14 (19), 4553, 2022
Mandater: US National Institutes of Health
Informasjon om publisering og finansiering fastsettes automatisk av et datamaskinprogram